Medications for Attention Deficit Hyperactivity Disorder

8 results

  • azstarys - serdexmethylphenidate and dexmethylphenidate capsule

    (Serdexmethylphenidate And Dexmethylphenidate)
    Corium, Llc.
    AZSTARYS treats Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. Not recommended for children under 6 due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions

  • concerta - methylphenidate hydrochloride tablet, extended release

    (Methylphenidate Hydrochloride)
    Janssen Pharmaceuticals, Inc.
    CONCERTA treats attention deficit hyperactivity disorder (ADHD) in patients aged 6 to 65 years. Not recommended for children under 6 due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions

  • dyanavel xr - amphetamine suspension, extended release

    (Amphetamine)
    Nextwave Pharmaceuticals, Inc
    DYANAVEL XR treats Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. Not recommended for children under 6 due to higher plasma exposure and adverse reactions.
    Medication Details
    Drug Interactions

  • jornay pm extended - release - methylphenidate hydrochloride capsule

    (Methylphenidate Hydrochloride)
    Ironshore Pharmaceuticals Inc.
    Jornay PM treats Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. Not recommended for children under 6 due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions

  • qelbree - viloxazine hydrochloride capsule, extended release

    (Viloxazine Hydrochloride)
    Supernus Pharmaceuticals, Inc
    Qelbree is indicated for the treatment of ADHD in adults and pediatric patients 6 years and older.
    Medication Details
    Drug Interactions

  • quillichew er - methylphenidate hydrochloride tablet, chewable, extended release

    (Methylphenidate Hydrochloride)
    Nextwave Pharmaceuticals, Inc
    QuilliChew ER treats Attention Deficit Hyperactivity Disorder (ADHD). Not recommended for children under 6 years old due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions

  • quillivant xr - methylphenidate hydrochloride suspension, extended release

    (Methylphenidate Hydrochloride)
    Nextwave Pharmaceuticals, Inc
    Quillivant XR treats Attention Deficit Hyperactivity Disorder (ADHD). Not recommended for children under 6 years old due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions